As of the close of early trading, the Nikkei 225 index fell by 1.2% and the Dongzheng index fell by 1.3%.FedEx signed a memorandum of understanding with Hong Kong Customs on the facilitation of cross-border express customs clearance. FedEx announced that it signed a memorandum of understanding with Hong Kong Customs on the facilitation of cross-border express customs clearance (CEFA) yesterday and became the first company to join the memorandum of understanding, which is expected to benefit from stable and efficient customs clearance procedures. CEFA aims to improve the efficiency of customs clearance of cross-border cargoes from the Mainland to Hong Kong. According to the Memorandum of Understanding, the Customs and Excise Department will provide customs clearance service for imported cargoes transported from the Mainland to Hong Kong at one of the FedEx service stations in the urban area of Hong Kong, and arrange for imported cargoes currently transported to Hong Kong by FedEx Guangzhou Asia-Pacific transshipment center to be transported by cross-border trucks equipped with electronic locks (E-locks) and global positioning systems (GPS).Zhendong Pharmaceutical has set up a new health management service company. The enterprise search APP shows that recently, Shanxi Zhendong Health Management Service Co., Ltd. was established, with Zhao Jin as the legal representative and a registered capital of 10 million yuan. Its business scope includes: remote health management services; Health consulting services (excluding medical services), etc. Enterprise investigation shows that the company is wholly owned by Zhendong Pharmaceutical.
Ha Sanlian: Four kinds of drugs are planned to win the bid for national centralized procurement. Ha Sanlian announced that the company and its wholly-owned subsidiary Lanxi Pharmaceutical participated in the tenth batch of national centralized procurement of drugs organized by the state. The company's esmolol hydrochloride injection, pentoxifylline injection, potassium chloride injection, and tandospirone citrate tablets of Lanxi Pharmaceutical intend to win the bid for this centralized procurement. If the subsequent purchase contract is signed and implemented, it will help to expand the sales of related products and improve the market share and brand influence. The prices of the above-mentioned drugs are respectively 1.34 yuan for esmolol hydrochloride injection, 0.59 yuan for pentoxifylline injection, 0.16 yuan for potassium chloride injection and 6.56 yuan for tandospirone citrate tablets.Defender said that Li Tie had not decided whether to appeal, and Li Tie's defender was interviewed by CCTV reporters outside the court. Regarding the first-instance judgment that Li Tie was sentenced to 20 years, the defender said that Li Tie had not decided whether to appeal, and he would negotiate with Li Tie again. Regarding the state of Li Tie's trial today, the defender's answer is: calm, peaceful and stable. (Tiantian Sports)[The yield of 30-year treasury bonds fell below the 2% mark, and the active bonds of 30-year treasury bonds fell below 2% by 4.26bp, reaching 1.9999% as of press time.
Wuzhou Spring today bought 101 million yuan and sold 140 million yuan on Shanghai Stock Connect. Wuzhou Spring today traded at a daily limit, with a turnover of 4.335 billion yuan and a turnover rate of 35.76%. After-hours data showed that Ningbo Sangtian Road mat bought 77.1945 million yuan, and Shanghai Stock Connect special seats bought 101 million yuan and sold 140 million yuan.Li Dongsheng said that low-price competition has no way out, and it will only get involved. On December 11th, at TCL Global Innovation Conference, founder Li Dongsheng said that in the current market competition, low-price competition has no way out, and it will only get involved in endless "involution". To surpass its competitors, it is necessary to strive for more breakthroughs in high-end products. He Jun, vice president of TCL Industry, talked about the current development of industrial software enterprises in China in a subsequent interview. He also said that from the aspects of financing environment and market support for enterprises, China is not an environment where good software enterprises can be born at present, but in the long run, industrial software may make a breakthrough in China software, and this time will not be very fast, and it will not be seen for three or five years.Goldman Sachs lowered the UK's GDP growth forecast for 2024 from the previous 1.2% to 1.0%.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
Strategy guide
12-14
Strategy guide 12-14